Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
IDXX Transcript
IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript
Positive2-2
The earnings call reflects strong financial performance with increased revenue and EPS guidance. Positive factors include significant growth in CAG Diagnostics, international expansion, and innovation in products like inVue and Cancer Dx. Despite some headwinds in wellness visits and pricing moderation, the overall outlook remains robust with improved margins and strategic expansion plans. The Q&A session confirms these positive trends, with management addressing concerns effectively, leading to a positive sentiment.
IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript
Positive11-3
IDEXX's earnings call highlights strong financial performance with increased revenue and EPS outlooks, robust organic growth across multiple sectors, and strategic investments in commercial expansion and innovation. The Q&A session reinforces positive trends, particularly in consumables and diagnostics, despite minor declines in some areas like rapid assays. Share repurchases and a focus on long-term growth through R&D and market expansion further bolster confidence. The overall sentiment is positive, with expectations of continued growth and innovation driving stock price upward.
IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Neutral9-9
IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript
Neutral8-4
IDXX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
